The HTA Philippines invites interested Filipino researchers to submit capsule proposals under the HTA Research Agenda 2024 – Batch 2 (Cycle 2 Topics)
The HTA Research Agenda 2024: Batch 2 (Cycle 2 Clinical Assessments) consists of prioritized health technology topics per disease area under the HTA general track.
- Chronic obstructive pulmonary disease (COPD)
- Breast cancer
- Lung cancer
- Ovarian cancer
- Diabetes mellitus (DM)
- Stroke
- Patients with liver lesions/pathologies
- Meningococcal infections
- Diffuse large B Cell Lymphoma
Expression of Interest Deadline: 24 September 2024
Submission Deadline: Within 10 days after expressing interest
Please refer to the attached call guidelines for detailed information on the topics and submission guidelines. [HTA Submission Guidelines]
Kindly email htaresearch@dost.gov.ph by 24 September 2024 to express your interest.